SCHEMBL5200183

SCHEMBL5200183

C=CC(C(=O)O)c1cnc2ccccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.50
RAB9A P51151 3/20 0.48
KDR P35968 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
ACP1 P24666 1/20 0.43
PDGFRB P09619 1/20 0.43
PDGFRA P16234 1/20 0.43
KDM4E B2RXH2 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
KMT2A Q03164 1/20 0.41
CFTR P13569 1/20 0.41
NQO1 P15559 1/20 0.41
NPC1 O15118 2/20 0.40
CYP1A2 P05177 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27606683 0.80 KDM4E (0.41) MGAMRAB9AKDM4ESMN1; SMN2KMT2A
SCHEMBL5998390 0.79 KDM4E (0.42) MGAMRAB9AAKR1C3AKR1C2PDGFRB
SCHEMBL372069 0.78 CYP1A2 (0.44) MGAMRAB9AKDRACP1PDGFRB
SCHEMBL5462379 0.78 CYP1A2 (0.44) MGAMRAB9AKDRACP1PDGFRB
SCHEMBL29800505 0.78 CYP1A2 (0.44) MGAMRAB9AKDRACP1PDGFRB
SCHEMBL846535 0.77 AKR1C3 (0.62) MGAMRAB9AKDRAKR1C3AKR1C2
SCHEMBL31016541 0.77 AKR1C3 (0.62) MGAMRAB9AKDRAKR1C3AKR1C2
SCHEMBL2631569 0.77 MGAM (0.54) MGAMRAB9AKDRAKR1C3AKR1C2
SCHEMBL29029194 0.77 PDGFRB (0.46) MGAMRAB9AKDRACP1PDGFRB
SCHEMBL30491145 0.77 PDGFRB (0.46) MGAMRAB9AKDRACP1PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262172-B2 Macrolides GLAXO GROUP LIMITED (GB) 2007-08-28 US disclosed
EP-1328535-B1 MACROLIDES GLAXO GROUP LTD (GB) 2007-08-15 EP disclosed
US-20040254124-A1 Macrolides PLIVA D.D. (HR) 2004-12-16 US disclosed
EP-1328535-A1 MACROLIDES GLAXO GROUP LIMITED (GB) 2003-07-23 EP disclosed
WO-2002032917-A1 MACROLIDES GLAXO GROUP LIMITED (GB) 2002-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254124-A1 Macrolides OGFOD1, TLR7, MALT1 MGAM 744/4885RAB9A 3060/4885KDR 4653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.